[go: up one dir, main page]

PT2836559T - Composição que compreende um diluente orgânico e um éter de celulose. - Google Patents

Composição que compreende um diluente orgânico e um éter de celulose.

Info

Publication number
PT2836559T
PT2836559T PT137176772T PT13717677T PT2836559T PT 2836559 T PT2836559 T PT 2836559T PT 137176772 T PT137176772 T PT 137176772T PT 13717677 T PT13717677 T PT 13717677T PT 2836559 T PT2836559 T PT 2836559T
Authority
PT
Portugal
Prior art keywords
composition
cellulose ether
organic diluent
diluent
organic
Prior art date
Application number
PT137176772T
Other languages
English (en)
Inventor
Adden Roland
L Sammler Robert
Brackhagen Meinolf
S Grasman Nicholas
Petermann Oliver
J Guillaudeu Steven
Original Assignee
Dow Global Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Llc filed Critical Dow Global Technologies Llc
Publication of PT2836559T publication Critical patent/PT2836559T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/193—Mixed ethers, i.e. ethers with two or more different etherifying groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/26—Cellulose ethers
    • C09D101/28—Alkyl ethers
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/26—Cellulose ethers
    • C09D101/28—Alkyl ethers
    • C09D101/284—Alkyl ethers with hydroxylated hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
PT137176772T 2012-04-11 2013-04-08 Composição que compreende um diluente orgânico e um éter de celulose. PT2836559T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261622757P 2012-04-11 2012-04-11

Publications (1)

Publication Number Publication Date
PT2836559T true PT2836559T (pt) 2016-08-31

Family

ID=48142997

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137176772T PT2836559T (pt) 2012-04-11 2013-04-08 Composição que compreende um diluente orgânico e um éter de celulose.

Country Status (8)

Country Link
US (1) US9757465B2 (pt)
EP (1) EP2836559B1 (pt)
JP (1) JP6185559B2 (pt)
KR (1) KR102065326B1 (pt)
CN (1) CN104364329B (pt)
BR (1) BR112014021506B1 (pt)
PT (1) PT2836559T (pt)
WO (1) WO2013154980A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101991230B1 (ko) * 2011-06-14 2019-06-21 다우 글로벌 테크놀로지스 엘엘씨 셀룰로스 에테르를 포함하는 식품 조성물
US9441117B2 (en) * 2012-03-20 2016-09-13 Basf Se Mixtures, methods and compositions pertaining to conductive materials
US9962446B2 (en) * 2012-07-17 2018-05-08 Dow Global Technologies Llc Solid dispersion comprising a highly substituted hydroxyalkyl methylcellulose
BR112015019577B1 (pt) * 2013-04-12 2022-02-08 Nutrition & Biosciences Usa 1, Llc Processo para preparar uma solução aquosa de uma metilcelulose, solução aquosa de uma metilcelulose livre de proteínas e medicamento, alimento, ingrediente de alimento ou suplemento alimentício
US20160120990A1 (en) * 2013-07-17 2016-05-05 Dow Global Technologies Llc Composition for application to a mucosa comprising a hydroxyalkyl methylcellulose
US10610491B2 (en) 2013-09-25 2020-04-07 Dow Global Technologies Llc Composition comprising an organic liquid diluent and a specific hydroxyalkyl methylcellulose
WO2015108768A1 (en) 2014-01-16 2015-07-23 Dow Global Technologies Llc Support materials for 3d printing
KR20180015662A (ko) * 2015-06-05 2018-02-13 다우 글로벌 테크놀로지스 엘엘씨 셀룰로오스 에테르 분말
JP6749944B2 (ja) * 2015-06-05 2020-09-02 ダウ グローバル テクノロジーズ エルエルシー セルロースエーテル粉末
CN107690458B (zh) * 2015-06-09 2020-07-24 陶氏环球技术有限责任公司 用于三维印刷的支撑材料
JP7526727B2 (ja) * 2018-12-18 2024-08-01 ニュートリション アンド バイオサイエンシズ ユーエスエー １，リミティド ライアビリティ カンパニー ヒドロキシアルキルメチルセルロースを含む徐放性組成物
KR20210052281A (ko) * 2019-10-29 2021-05-10 신에쓰 가가꾸 고교 가부시끼가이샤 캡슐 충전용 조성물 및 이것을 사용한 캡슐 제제의 제조 방법 그리고 캡슐 제제
CN113637088B (zh) * 2021-10-18 2021-12-24 高密银鹰新材料股份有限公司 一种减少纤维素醚生产过程中产生黑黄点的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2613142A (en) 1948-05-11 1952-10-07 Sol B Wiczer Alcohol fuel gel
US3477864A (en) 1965-05-07 1969-11-11 Sumitomo Chemical Co Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film
GB1144225A (en) 1965-09-07 1969-03-05 Dow Chemical Co Preparation of medicinal capsule shells from hydroxyalkyl-alkyl cellulose ethers
DE2917104A1 (de) 1979-04-27 1980-11-06 Hoechst Ag Verfahren zur viskositaetserniedrigung von celluloseethern durch ozon und seine verwendung
JPS6225101A (ja) 1985-07-24 1987-02-03 Shin Etsu Chem Co Ltd 低重合度セルロ−スエ−テルの製造方法
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
US5723151A (en) * 1995-11-06 1998-03-03 Eastman Chemical Company Cellulose acetate phthalate enteric coating compositions
EP0872233A1 (en) 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretroviral compositions with improved bioavailability
US6261218B1 (en) 1998-12-01 2001-07-17 The Dow Chemical Company Process and apparatus for making low molecular weight cellulose ethers
US6235893B1 (en) * 1999-04-01 2001-05-22 The Dow Chemical Company Process for making cellulose ether having enhanced gel strength
WO2001022938A1 (en) * 1999-09-24 2001-04-05 Janssen Pharmaceutica N.V. Antiviral compositions
KR20010097244A (ko) 2000-04-21 2001-11-08 유충식 위산도 비의존성 고용해도를 갖는 이트라코나졸 함유약학적 조성물 및 그 제조방법
DE10038978A1 (de) * 2000-08-10 2002-02-21 Wolff Walsrode Ag Verfahren zur Herstellung von Alkylhydroxyalkylcellulose
DE10141680B4 (de) 2001-08-25 2004-02-26 Clariant Gmbh Verfahren zur Herstellung niederviskoser Celluloseether durch sauer-oxidativen Abbau von gemahlenen und getrockneten Celluloseethern
DE10233788A1 (de) * 2002-07-25 2004-02-05 Wolff Cellulosics Gmbh & Co. Kg Cellulosederivate mit gel-artigen rheologischen Eigenschaften und Verfahren zur Herstellung derselben
US20060083784A1 (en) * 2002-08-07 2006-04-20 Smithkline Beecham Corporation Amorphous pharmaceutical compositions
US7666918B2 (en) 2004-03-17 2010-02-23 Dow Global Technologies, Inc. Foams made from interpolymers of ethylene/α-olefins
JP2008501009A (ja) * 2004-05-28 2008-01-17 ファイザー・プロダクツ・インク 性能を高めた医薬組成物
MY148074A (en) * 2005-05-10 2013-02-28 Novartis Ag Pharmaceutical compositions comprising imatinib and a release retardant
JP5529538B2 (ja) * 2006-09-29 2014-06-25 ユニオン カーバイド ケミカルズ アンド プラスティックス テクノロジー エルエルシー パーソナルケア製品用の４級化セルロースエーテル
US8372836B2 (en) 2006-10-17 2013-02-12 Bend Research, Inc. Spray dried formulation
US20080262216A1 (en) * 2007-04-20 2008-10-23 Shin-Etsu Chemical Co., Ltd. Hydroxyalkyl methylcellulose having solubility and thermoreversible gelation properties improved
BR112013005642B1 (pt) * 2010-10-12 2021-12-07 Nutrition & Biosciences Usa 1, Llc Éter de celulose, composição aquosa para a manufatura de cápsulas ou revestimentos, processo para a manufatura de cápsulas, processo para revestir uma forma de dosagem, invólucro de cápsula, cápsula e forma de dosagem
EP2663292B9 (en) * 2011-01-10 2017-11-08 Celgene Corporation Oral dosage forms of cyclopropanecarboxylic acid {2-[(1s)-1-(3-ethoxy-4-methoxy-phenyl]-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amide
BR112014020719B1 (pt) * 2012-04-11 2020-03-03 Dow Global Technologies Llc Forma de dosagem de liberação constante, método para preparar uma forma de dosagem de liberação constante e uso de um éter de celulose

Also Published As

Publication number Publication date
EP2836559A1 (en) 2015-02-18
US20150065548A1 (en) 2015-03-05
CN104364329B (zh) 2016-08-17
KR102065326B1 (ko) 2020-01-13
WO2013154980A1 (en) 2013-10-17
JP6185559B2 (ja) 2017-08-23
CN104364329A (zh) 2015-02-18
US9757465B2 (en) 2017-09-12
KR20140144297A (ko) 2014-12-18
BR112014021506B1 (pt) 2020-06-16
EP2836559B1 (en) 2016-05-25
JP2015512941A (ja) 2015-04-30

Similar Documents

Publication Publication Date Title
PT2836559T (pt) Composição que compreende um diluente orgânico e um éter de celulose.
GB201317141D0 (en) Well Isolation
HK1180931A1 (en) An electro-pulsograph
EP2870426A4 (en) FOLDABLE SHADE
HUP1200534A3 (en) Coaxial loudspeker arrangemet
EP2807563A4 (en) NETWORK TROUBLESHOOTING
HK1202445A1 (en) New formulation
SG11201500989SA (en) An Antifungal Compound
HK1207454A1 (en) Field analyzer
GB201214826D0 (en) Oxidised cellulose
EP2881792A4 (en) PELLICLE
SG11201504433VA (en) Silicone-compatible photoinitiators
PL2711141T3 (pl) Składany stół montażowy
EP2911002A4 (en) RESIST COMPOSITION
GB201220661D0 (en) RF Transformer
GB201222183D0 (en) Polysaccharides
GB2508001B (en) RF transformer
EP2799403A4 (en) TUBULAR DIGESTER
GB201322031D0 (en) Trestle assembly
AU4752P (en) WP09 MAR05 Dianthus x allwoodii
AU5379P (en) WP11 GWE04 Dianthus allwoodii
AU5372P (en) WP09 WEN04 Dianthus x allwoodii
AU5177P (en) Jade-AU Vigna radiata
AU2012902726A0 (en) Spreadsheet improvements
GB2507999B (en) RF transformer